Literature DB >> 3370833

Urinary albumin excretion in healthy adult subjects: reference values and some factors affecting their interpretation.

G F Watts1, R W Morris, K Khan, A Polak.   

Abstract

A conventional radioimmunoassay has been used to measure urinary albumin concentration in overnight, recumbent and daytime, ambulant samples from 127 healthy, normotensive volunteers (mean age 33.3 yr SD 12.4; 59 males, 68 females). Reference values were obtained for urine albumin concentration (mg/l), albumin/creatinine ratio (mg/mmol), and albumin excretion rate (microgram/min). The frequency distributions of these variables were positively skewed, but became Gaussian on logarithmic transformation of the data. Albumin excretion was significantly higher in daytime, ambulant samples than in overnight, recumbent samples (p less than 0.001). Surface area was not correlated with urine albumin concentration but it was negatively correlated with urine albumin/creatinine ratio (p less than 0.05) due to the association between surface area and creatinine excretion. Urine albumin concentration was negatively correlated with age, but this was due to a higher urine flow rate in older subjects. There was no significant association with sex or with mean arterial blood pressure in the normal range. Two repeated measurements showed that variability was high and comparable for urine albumin concentration, albumin/creatinine ratio and albumin excretion rate: it was not significantly less in overnight, recumbent than in day-time, ambulant samples.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3370833     DOI: 10.1016/0009-8981(88)90323-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Microalbuminuria: timing is everything!

Authors:  Peter Gosling; Mav Manji; John Czyz
Journal:  Intensive Care Med       Date:  2003-05-22       Impact factor: 17.440

2.  Biological effect monitoring of occupational exposure to 1,3-dichloropropene: effects on liver and renal function and on glutathione conjugation.

Authors:  N J Van Sittert; G E Veenstra; E P Dumas; W F Tordoir
Journal:  Br J Ind Med       Date:  1991-09

3.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

4.  Microalbuminuria as predictor of outcome. Shows promise but large prospective trials are needed.

Authors:  G Evans; I Greaves
Journal:  BMJ       Date:  1999-01-23

5.  The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients.

Authors:  Z Molnar; K L MacKinnon; E Shearer; D Lowe; I D Watson
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

6.  Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Zsolt Molnar; Tamas Szakmany; Tamas Koszegi
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

7.  [Urinary proteins as indicators of diabetic nephropathy].

Authors:  M H Weber
Journal:  Klin Wochenschr       Date:  1988-09-15

8.  Urinary albumin excretion and transcapillary escape rate of albumin in malignancies.

Authors:  L M Pedersen; L Terslev; P G SŁrensen; K H Stokholm
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

9.  Increased albumin excretion in industrial workers due to shift work rather than to prolonged exposure to low concentrations of chlorinated hydrocarbons.

Authors:  P J Boogaard; M E Caubo
Journal:  Occup Environ Med       Date:  1994-09       Impact factor: 4.402

10.  Hydrocarbon exposure, hypertension and kidney function tests.

Authors:  P Hotz; J Pilliod; A Bernard; M Berode; F Rey; C Mazzocato; M Guillemin; M A Boillat
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.